Miguel A. Rodrı́guez-Bigas

Author

The University of Texas MD Anderson Cancer Center ORCID

Also Known As

A T Stormorken, Albert C Koong, International Collaborative Group on HNPCC, M A Rodriguez-Bigas, M Rodriguez-Bigas, M. A. Rodriguez-Bigas, M. A. Rodriguez‐Bigas, M. A. Rodríguez-Bigas, M. Rodriguez-Bigas, M.A. Rodriguez-Bigas

400

Publications

27.3K

Citations

H-Index

116

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center Roswell Park Comprehensive Cancer Center Society of Surgical Oncology University at Buffalo, State University of New York

About

Miguel A. Rodrı́guez-Bigas is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	45	85	13.8K
2	Health Sciences	15	18	1.2K
3	Public Health	8	8	4.3K
4	Engineering	1	1	387
5	Natural Sciences	1	1	78

Miguel A. Rodrı́guez-Bigas

177

Publications

24.5K

Citations

H-Index

Page 1

	Year	Citations
A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. C. Richard Boland, Stephen N. Thibodeau, Stanley R. Hamilton, PubMed Genetic TestingCancer PathologyGeneticsGenetic EpidemiologyPathology	1998	4.1K
Revised Bethesda Guidelines for Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome) and Microsatellite Instability Asad Umar, C. Richard Boland, Jonathan P. Terdiman, JNCI Journal of the National Cancer Institute Lynch SyndromeCancer PathologyMedicineGeneticsMicrosatellite Instability	2004	3.2K
The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous Polyposis Gideon Steinbach, Patrick M. Lynch, Robin Phillips, New England Journal of Medicine	2000	2.5K
A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: Meeting Highlights and Bethesda Guidelines Miguel A. Rodrı́guez-Bigas, C. Richard Boland, Stanley R. Hamilton, JNCI Journal of the National Cancer Institute Cancer PathologyGastrointestinal OncologyMedicineGenetic EpidemiologyColorectal Cancer	1997	1.1K
Increasing Disparities in the Age-Related Incidences of Colon and Rectal Cancers in the United States, 1975-2010 Christina E. Bailey, Chung-Yuan Hu, Y. Nancy You, JAMA Surgery	2014	1.1K
Neoadjuvant Treatment Response As an Early Response Indicator for Patients With Rectal Cancer In Ja Park, Y. Nancy You, Atin Agarwal, Journal of Clinical Oncology	2012	493
The onset and extent of genomic instability in sporadic colorectal tumor progression Daniel L. Stoler, Neng Chen, Mark Basik, Proceedings of the National Academy of Sciences EngineeringGeneticsPathologyNatural SelectionCarcinoma Cell Genomes	1999	387
Clinicopathology and Outcomes for Mucinous and Signet Ring Colorectal Adenocarcinoma: Analysis from the National Cancer Data Base John Hyngstrom, Chung-Yuan Hu, Yan Xing, Annals of Surgical Oncology Gastrointestinal OncologyMedicineSurgical PathologyColorectal CancerPathology	2012	344
Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer Prajnan Das, John M. Skibber, Miguel A. Rodrı́guez-Bigas, Cancer	2007	337
Outcomes of Immediate Vertical Rectus Abdominis Myocutaneous Flap Reconstruction for Irradiated Abdominoperineal Resection Defects Charles E. Butler, Özlem Gündeşlioğlu, Miguel A. Rodrı́guez-Bigas Journal of the American College of Surgeons	2008	295

Page 1